Evidence map›Paper›PMID 42643519›Full record

ArticleTherapeutic advances in hematology2026

Successful treatment of relapsed

Jialiang Xu, Yangpeng Chen, Yan Zhang, Fuhua Zhang, Yu Zhang, Jing Sun, Na Xu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jialiang XuDepartment of Hematology, School of Medicine, the Sixth Affiliated Hospital of South China University of Technology (Nanhai District People's Hospital of Foshan), Foshan, Guangdong, China.ORCID https://orcid.org/0000-0003-4438-1506
Yangpeng ChenDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yan ZhangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Fuhua ZhangDepartment of Hematology, School of Medicine, the Sixth Affiliated Hospital of South China University of Technology (Nanhai District People's Hospital of Foshan), Foshan, Guangdong, China.
Yu ZhangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jing SunDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Na XuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes the successful treatment of a patient with acute monocytic leukemia (AML-M5), positive for the

Indexed as

central nervous system involvementKMT2A-rearrangedmenin inhibitorrelapsed acute myeloid leukemia

Identifiers

PMID42643519
PMCPMC13504113

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.